- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Impaired Glucose Tolerance in South Africa
Total 899 results
-
SanofiCompletedType 2 Diabetes MellitusSouth Africa, United States, Mexico, United Kingdom
-
SanofiCompletedType 2 Diabetes MellitusArgentina, Colombia, Egypt, Hong Kong, India, Indonesia, Lebanon, Malaysia, Peru, Philippines, Saudi Arabia, South Africa, Thailand, Turkey
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2United States, Argentina, Portugal, South Africa
-
SanofiCompletedType 2 Diabetes MellitusFrance, Poland, Germany, Italy, Netherlands, Belgium, Denmark, Chile, South Africa, Australia, Argentina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Bahrain, Egypt, Jordan, Kuwait, Qatar, South Africa, United Arab Emirates
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Denmark, Croatia, Australia, South Africa, Italy, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSouth Africa
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, France, Israel, Mexico, South Africa
-
SanofiCompletedType 2 Diabetes MellitusMexico, South Africa, United States, Mauritius, Spain, Turkey
-
University of South CarolinaCompletedPhysical Activity | Sedentary Lifestyle | Metabolism Disorder, GlucoseUnited States
-
Actinogen MedicalAXIOM Real Time MetricsActive, not recruitingCognitive Impairment | Major Depressive Disorder | MDDAustralia, United Kingdom
-
University of AdelaideCompletedInsulin ResistanceAustralia
-
Solvay PharmaceuticalsQuintiles, Inc.TerminatedCongestive Heart FailureUnited States, Argentina, Belgium, Czech Republic, Former Serbia and Montenegro, Germany, Poland, Russian Federation, South Africa, Spain
-
University of AdelaideRoyal Adelaide Hospital; University of South AustraliaTerminatedInsulin ResistanceAustralia
-
SanofiCompletedType 2 Diabetes MellitusFrance, Russian Federation, United States, Argentina, Canada, Germany, South Africa, Italy, Netherlands, United Kingdom, Australia, Chile
-
Ionis Pharmaceuticals, Inc.CompletedType 2 Diabetes MellitusCanada, Romania, South Africa
-
Harokopio UniversityCompleted
-
Garvan Institute of Medical ResearchCompleted
-
Konstantinos Makrilakis, MDUni-PharmaEnrolling by invitationDiabetes Mellitus, Type 2Greece
-
Harokopio UniversityCompletedDiabetes Mellitus, Type 2Greece
-
AstraZenecaRecruitingHeart Failure and Impaired Kidney FunctionSpain, France, Germany, Italy, United States, Argentina, Czechia, Vietnam, Peru, China, Philippines, Saudi Arabia, Australia, Austria, Canada, Japan, Malaysia, Poland, Taiwan, Thailand, Israel, Brazil, Finland, Greece, Mexico, United Kingdom and more
-
Harokopio UniversityUniversity of Thessaly; University of Ioannina; University of Patras; CitiesNet; ... and other collaboratorsRecruiting
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, South Africa, Hong Kong, Taiwan, Philippines
-
Harokopio UniversityNational and Kapodistrian University of Athens; Technische Universität Dresden and other collaboratorsUnknown
-
Chung Shan Medical UniversityCompleted
-
AstraZenecaCompletedType 2 DiabetesUnited States, Russian Federation, South Africa, Taiwan
-
Millennium Pharmaceuticals, Inc.TerminatedCritical Illness | Enteral Nutrition | Enteral Feeding IntoleranceUnited States, Canada, Australia, United Kingdom
-
University of AdelaideCompletedInsulin Resistance | Type 2 DiabetesAustralia
-
Sheffield Hallam UniversityNewcastle University; Teesside University; Northumbria UniversityCompletedMetabolic SyndromeUnited Kingdom
-
University of VermontNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedInsulin Resistance | Adipocyte DifferentiationUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMorocco, Tunisia, Algeria, South Africa, Egypt
-
University of NebraskaIndian Health Service (IHS)CompletedStress, Psychological | Insulin ResistanceUnited States
-
Medical University of South CarolinaUniversity of North Carolina, Chapel Hill; North Carolina Translational and... and other collaboratorsCompleted
-
SanofiCompletedDiabetes Mellitus, Type 1Tunisia, South Africa, Algeria, Argentina, Brazil, Colombia, Kuwait, Mexico, Saudi Arabia
-
Ionis Pharmaceuticals, Inc.CompletedType 2 Diabetes MellitusUnited States, South Africa
-
US Department of Veterans AffairsCompletedDiabetesUnited States
-
University of AdelaideCompletedDiabetes | Metabolic SyndromeAustralia
-
Hasanuddin UniversityCompletedObesity | Insulin ResistanceIndonesia
-
Medical University of South CarolinaTakeda Pharmaceuticals North America, Inc.CompletedDiabetesUnited States
-
The George InstituteNational Health and Medical Research Council, Australia; University of British... and other collaboratorsCompletedHyperglycemia | Critical IllnessAustralia
-
Cardiff UniversityDiabetes UKTerminated
-
FORUM Pharmaceuticals IncSyneos Health; NeuroCog Trials, Inc.CompletedSchizophrenia | Impaired CognitionUnited States, Ukraine, United Kingdom, Poland, Romania, Russian Federation, Italy, Mexico, Colombia, Argentina, Australia, Brazil
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada, Romania, Russian Federation, Ukraine, Germany, Spain, Philippines, Czech Republic, Mexico, Croatia, Chile, Morocco, South Africa, Australia, Venezuela
-
Neurocrine BiosciencesCompletedType 1 Diabetes MellitusSpain, Finland, Canada, France, Czech Republic, Germany, South Africa, United Kingdom
-
University of AdelaideCompletedObesity | Type 2 DiabetesAustralia
-
University of AdelaideCompletedObesity | Type 2 DiabetesAustralia
-
FORUM Pharmaceuticals IncSyneos HealthCompletedSchizophrenia | Impaired CognitionUnited States, Ukraine, United Kingdom, Germany, Spain, Argentina, Canada, Singapore, Russian Federation, Italy, Mexico, Colombia, Australia, Belgium, Poland, Romania
-
Dionyssiotis, Yannis, M.D.University of ThessalyCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Malaysia, South Africa, Philippines, Australia, India, Saudi Arabia
-
GlaxoSmithKlineTerminated